Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 2
1914 2
1918 1
1920 1
1947 1
1948 3
1949 2
1950 3
1951 2
1952 3
1955 2
1957 1
1958 1
1959 3
1960 1
1964 1
1966 1
1967 2
1971 1
1973 1
1974 1
1975 4
1976 1
1977 2
1978 6
1979 3
1980 4
1981 3
1982 4
1983 2
1984 5
1985 4
1986 6
1987 12
1988 6
1989 8
1990 15
1991 15
1992 10
1993 12
1994 8
1995 11
1996 8
1997 17
1998 15
1999 27
2000 14
2001 11
2002 13
2003 5
2004 20
2005 45
2006 40
2007 48
2008 63
2009 52
2010 55
2011 68
2012 66
2013 80
2014 79
2015 77
2016 74
2017 57
2018 91
2019 104
2020 94
2021 105
2022 99
2023 82
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

1,514 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ, Hutfless S, Bass EB. Subramaniam RM, et al. Among authors: bass eb. Ann Intern Med. 2016 Mar 15;164(6):406-16. doi: 10.7326/M15-1456. Epub 2016 Feb 2. Ann Intern Med. 2016. PMID: 26830221 Free article. Review.
DATA EXTRACTION: Two reviewers independently extracted data and assessed study quality. DATA SYNTHESIS: Low-dose N-acetylcysteine plus IV saline compared with IV saline (risk ratio [RR], 0.75 [95% CI, 0.63 to 0.89]; low SOE), N-acetylcysteine plus IV saline compared …
DATA EXTRACTION: Two reviewers independently extracted data and assessed study quality. DATA SYNTHESIS: Low-dose N-acetylcysteine plu …
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH. Yeh HC, et al. Among authors: bass eb. Ann Intern Med. 2012 Sep 4;157(5):336-47. doi: 10.7326/0003-4819-157-5-201209040-00508. Ann Intern Med. 2012. PMID: 22777524 Free article. Review.
STUDY SELECTION: 33 randomized, controlled trials in children or adults that compared CSII with MDI (n=19), rt-CGM with SMBG (n=10), or sensor-augmented insulin pump use with MDI and SMBG (n=4). ...
STUDY SELECTION: 33 randomized, controlled trials in children or adults that compared CSII with MDI (n=19), rt-CGM with SMBG (n …
The effect of therapeutic horseback riding on social functioning in children with autism.
Bass MM, Duchowny CA, Llabre MM. Bass MM, et al. J Autism Dev Disord. 2009 Sep;39(9):1261-7. doi: 10.1007/s10803-009-0734-3. Epub 2009 Apr 7. J Autism Dev Disord. 2009. PMID: 19350376 Clinical Trial.
We hypothesized that participants in the experimental condition (n = 19), compared to those on the wait-list control (n = 15), would demonstrate significant improvement in social functioning following a 12-weeks horseback riding intervention. ...
We hypothesized that participants in the experimental condition (n = 19), compared to those on the wait-list control (n = 15), …
Rheumatic Complications of Immune Checkpoint Inhibitors.
Ghosh N, Bass AR. Ghosh N, et al. Among authors: bass ar. Rheum Dis Clin North Am. 2022 May;48(2):411-428. doi: 10.1016/j.rdc.2022.02.002. Rheum Dis Clin North Am. 2022. PMID: 35400368 Review.
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
Keller RB, Mazor T, Sholl L, Aguirre AJ, Singh H, Sethi N, Bass A, Nagaraja AK, Brais LK, Hill E, Hennessey C, Cusick M, Del Vecchio Fitz C, Zwiesler Z, Siegel E, Ovalle A, Trukhanov P, Hansel J, Shapiro GI, Abrams TA, Biller LH, Chan JA, Cleary JM, Corsello SM, Enzinger AC, Enzinger PC, Mayer RJ, McCleary NJ, Meyerhardt JA, Ng K, Patel AK, Perez KJ, Rahma OE, Rubinson DA, Wisch JS, Yurgelun MB, Hassett MJ, MacConaill L, Schrag D, Cerami E, Wolpin BM, Nowak JA, Giannakis M. Keller RB, et al. Among authors: bass a. JCO Precis Oncol. 2023 Jan;7:e2200342. doi: 10.1200/PO.22.00342. JCO Precis Oncol. 2023. PMID: 36634297 Free PMC article.
Summary reports were provided to 19 medical oncologists for patients with colorectal (n = 198, 39%), pancreatic (n = 124, 24%), esophagogastric (n = 67, 13%), biliary (n = 40, 8%), and other GI cancers. ...
Summary reports were provided to 19 medical oncologists for patients with colorectal (n = 198, 39%), pancreatic (n = 124, 24%) …
Supplements to treat prediabetes.
Hepler C, Bass J. Hepler C, et al. Among authors: bass j. Science. 2021 Jun 11;372(6547):1147-1148. doi: 10.1126/science.abj0764. Science. 2021. PMID: 34112679 Free PMC article. No abstract available.
The pharmacogenetics of type 2 diabetes: a systematic review.
Maruthur NM, Gribble MO, Bennett WL, Bolen S, Wilson LM, Balakrishnan P, Sahu A, Bass E, Kao WH, Clark JM. Maruthur NM, et al. Among authors: bass e. Diabetes Care. 2014;37(3):876-86. doi: 10.2337/dc13-1276. Diabetes Care. 2014. PMID: 24558078 Free PMC article. Review.
Quality evaluations were based on the Strengthening the Reporting of Genetic Association Studies guidelines and Human Genome Epidemiology Network guidance. RESULTS: Of 7,279 citations, we included 34 articles (N = 10,407) evaluating metformin (n = 14), sulfonylureas …
Quality evaluations were based on the Strengthening the Reporting of Genetic Association Studies guidelines and Human Genome Epidemiology Ne …
Improved Syntheses of Halogenated Benzene-1,2,3,4-Tetracarboxylic Diimides.
Zou B, Stellmach KA, Luo SM, Gebresilassie FL, Jung H, Zhang CK, Bass AD, Janzen DE, Cao DD. Zou B, et al. Among authors: bass ad. J Org Chem. 2022 Nov 4;87(21):13605-13614. doi: 10.1021/acs.joc.2c01241. Epub 2022 Oct 5. J Org Chem. 2022. PMID: 36198127
The preparation of halogenated benzene-1,2,3,4-tetracarboxylic diimide derivatives is challenging because of the possibility of competitive incorrect cyclizations and S(N)Ar reactivity. Here, we demonstrate that bypassing traditional cyclic anhydrides and instead directly …
The preparation of halogenated benzene-1,2,3,4-tetracarboxylic diimide derivatives is challenging because of the possibility of competitive …
Contrast-Induced Nephropathy: Comparative Effectiveness of Preventive Measures [Internet].
Subramaniam RM, Wilson RF, Turban S, Suarez-Cuervo C, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ, Hutfless S, Bass EB. Subramaniam RM, et al. Among authors: bass eb. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 15(16)-EHC023-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 15(16)-EHC023-EF. PMID: 26866209 Free Books & Documents. Review.
RESULTS: We found 163 randomized controlled trials (RCTs) and 23 prospective studies of interventions to prevent CIN, including 67 RCTs comparing N-acetylcysteine with IV saline versus IV saline with or without a placebo; 28 RCTs comparing IV sodium bicarbonate versus IV s …
RESULTS: We found 163 randomized controlled trials (RCTs) and 23 prospective studies of interventions to prevent CIN, including 67 RCTs comp …
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Patel J, Bass D, Beishuizen A, Bocca Ruiz X, Boughanmi H, Cahn A, Colombo H, Criner GJ, Davy K, de-Miguel-Díez J, Doreski PA, Fernandes S, François B, Gupta A, Hanrott K, Hatlen T, Inman D, Isaacs JD, Jarvis E, Kostina N, Kropotina T, Lacherade JC, Lakshminarayanan D, Martinez-Ayala P, McEvoy C, Meziani F, Monchi M, Mukherjee S, Muñoz-Bermúdez R, Neisen J, O'Shea C, Plantefeve G, Schifano L, Schwab LE, Shahid Z, Shirano M, Smith JE, Sprinz E, Summers C, Terzi N, Tidswell MA, Trefilova Y, Williamson R, Wyncoll D, Layton M. Patel J, et al. Among authors: bass d. Eur Respir J. 2023 Feb 2;61(2):2101870. doi: 10.1183/13993003.01870-2021. Print 2023 Feb. Eur Respir J. 2023. PMID: 36229048 Free PMC article. Clinical Trial.
The primary outcome was the proportion of patients alive and free of respiratory failure at Day 28. RESULTS: In Part 1 (n=806 randomised 1:1 otilimab:placebo), 71% of otilimab-treated patients were alive and free of respiratory failure at Day 28 versus 67% who received pla …
The primary outcome was the proportion of patients alive and free of respiratory failure at Day 28. RESULTS: In Part 1 (n=806 randomi …
1,514 results